Enantiodivergent α‑Amino C–H Fluoroalkylation Catalyzed by Engineered Cytochrome P450s

The introduction of fluoroalkyl groups into organic compounds can significantly alter pharmacological characteristics. One enabling but underexplored approach for the installation of fluoroalkyl groups is selective C­(sp 3)–H functionalization due to the ubiquity of C–H bonds in organic molecules. W...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Chemical Society Vol. 141; no. 25; pp. 9798 - 9802
Main Authors: Zhang, Juner, Huang, Xiongyi, Zhang, Ruijie K, Arnold, Frances H
Format: Journal Article
Language:English
Published: United States American Chemical Society 26-06-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The introduction of fluoroalkyl groups into organic compounds can significantly alter pharmacological characteristics. One enabling but underexplored approach for the installation of fluoroalkyl groups is selective C­(sp 3)–H functionalization due to the ubiquity of C–H bonds in organic molecules. We have engineered heme enzymes that can insert fluoroalkyl carbene intermediates into α-amino C­(sp 3)–H bonds and enable enantiodivergent synthesis of fluoroalkyl-containing molecules. Using directed evolution, we engineered cytochrome P450 enzymes to catalyze this abiological reaction under mild conditions with total turnovers (TTN) up to 4070 and enantiomeric excess (ee) up to 99%. The iron-heme catalyst is fully genetically encoded and configurable by directed evolution so that just a few mutations to the enzyme completely inverted product enantioselectivity. These catalysts provide a powerful method for synthesis of chiral organofluorine molecules that is currently not possible with small-molecule catalysts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present Addresses
J.Z. and X.H. contributed equally.
R.K.Z: Research and Development, Amyris Inc., 5885 Hollis Street, Suite 100, Emeryville, CA 94608 United States.
Author Contributions
ISSN:0002-7863
1520-5126
DOI:10.1021/jacs.9b04344